Skip to main content
Article
Haploidentical Bone Marrow Transplantation Using Anti-CD45 Radioimmunotherapy to Decrease Relapse in a Pre-Clinical Murine Model
Biology of Blood and Marrow Transplantation (2012)
  • A. Kenoyer, Fred Hutchinson Cancer Research Center
  • J.J. Orozco, Fred Hutchinson Cancer Research Center
  • D.K. Hamlin, University of Washington
  • D.S. Wilbur, University of Washington
  • D.R. Fisher, Pacific Northwest National Laboratory
  • M.D. Hylarides, Fred Hutchinson Cancer Research Center
  • A. Axtman, Fred Hutchinson Cancer Research Center
  • S.L. Frayo, Fred Hutchinson Cancer Research Center
  • D.J. Green, Fred Hutchinson Cancer Research Center
  • A.K. Gopal, Fred Hutchinson Cancer Research Center
  • P. O'Donnell, Fred Hutchinson Cancer Research Center
  • O.W. Press, Fred Hutchinson Cancer Research Center
  • J.M. Pagel, Fred Hutchinson Cancer Research Center
Publication Date
January 2, 2012
DOI
10.1016/j.bbmt.2011.12.062
Citation Information
A. Kenoyer, J.J. Orozco, D.K. Hamlin, D.S. Wilbur, et al.. "Haploidentical Bone Marrow Transplantation Using Anti-CD45 Radioimmunotherapy to Decrease Relapse in a Pre-Clinical Murine Model" Biology of Blood and Marrow Transplantation Vol. 18 Iss. 2 (2012)
Available at: http://works.bepress.com/john-pagel/159/